Overview

Oxytocin for Hypermobile Ehlers-Danlos Syndrome

Status:
Enrolling by invitation
Trial end date:
2024-05-13
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to evaluate effect of IV oxytocin on chronic pain in patients with Hypermobile Ehlers Danlos syndrome.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Baylor College of Medicine
Treatments:
Oxytocin